Senolytic Drug Market Size, Share 2023

The global senolytic drug market size is projected to reach $10.2 billion by 2030, from $1.5 billion in 2022, growing at a CAGR of 25.3% during 2022-2030.

This report contains market size and forecasts of Senolytic Drug in Global, including the following market information:

Report Sample includes:
- Table of Contents
- List of Tables & Figures
- Charts
- Research Methodology

Get FREE Sample of this Report at https://www.statsmarketresearch.com/download-free-sample/7534531/global-senolytic-drug-forecast-2023-2030-282

• Global Senolytic Drug Market Revenue, 2018-2023, 2023-2030, ($ millions)

• Global top five companies in 2022 (%)

FOXO4-related Peptides Segment to Reach $ Million by 2030, with a % CAGR in next six years.

The global key manufacturers of Senolytic Drug include AgeX Therapeutics, Inc., Cleara Biotech, Eternans Ltd., FoxBio Inc, Numeric Biotech, T.A. Sciences, Inc. and Recursion Pharmaceuticals, Inc., etc. In 2022, the global top five players have a share approximately % in terms of revenue.

We surveyed the Senolytic Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks. Total Market by Segment:

Global Senolytic Drug Market, by Type, 2018-2023, 2023-2030 ($ millions)

Global Senolytic Drug Market Segment Percentages, by Type, 2022 (%)

• FOXO4-related Peptides

• Bcl-2 Family Inhibitors

• Navitoclax

• Dasatinib and Quercetin

• Others

Global Senolytic Drug Market, by Application, 2018-2023, 2023-2030 ($ millions)

Global Senolytic Drug Market Segment Percentages, by Application, 2022 (%)

• Retail Pharmacies

• Hospital Pharmacies

• Online Pharmacies

Global Senolytic Drug Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions)

Global Senolytic Drug Market Segment Percentages, By Region and Country, 2022 (%)

• North America (United States, Canada, Mexico)